CBBS: Therapeutic Apheresis

Therapeutic Apheresis Issues

Date Posted	Subject
Jan. 12, 2012	Fibrinogen levels and therapeutic plasma exchange
Dec. 4, 2011	Pre-procedure physical exams in therapeutic apheresis patients
Aug. 11, 2009	Plasma infusion instead of plasma exchange for maintenence of a remission in a patient with ADAMTS-13 synthetic defect causing relapsing TTP ADDENDA Aug. 18
Feb. 21, 2009	Hemapheresis services for neonates ADDENDA Mar. 19 & 24
Jan. 18, 2008	Plasmapheresis of recipients who undergo transplantation of ABO mismatched bone marrow/PBSC
Feb. 9, 2007	Importance of language: Plasmapheresis vs plasma exchange ADDENDA Feb. 20
Jan. 2, 2007	Data or experience to support the use of plasma exchange in anti-GBM negative, ANCA negative pauci-immune RPGN
Jan. 2, 2007	Fluid replacement practices in plasma exchange when FFP alone is not indicated
Dec. 22, 2006	Checking plasma fibrinogen levels for patients undergoing a series of Therapeutic Plasma Exchange (TPE) procedures using 5% albumin as replacement fluid
Nov. 20, 2006	How are hospitals that use 5% albumin as a replacement fluid for some therapeutic plasma exchange procedures addressing a lack of supply of that solution? Do colleagues consider the use of plasma protein fraction to be a safe alternative? ADDENDA Nov. 22; Aug. 21 & 29, 2008
Dec. 22, 2005	Criteria for selection of plasma products when performing therapeutic plasma exchange for TTP patients ADDENDA Dec. 23, 27 & 28
May 3, 2005	Preparation, storage and expiration of pooled plasma used for TPE procedures ADDENDA May 4, 5 & 10
July 10, 2004	Protocols for apheresis in treating heart/kidney transplant rejection ADDENDA July 13 & Aug. 2
Mar. 5, 2003	High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome ADDENDA Mar. 7 & 10
Nov. 5, 2002	Status of automated red cell exchanges (ARBCx) as a treatment modality in sickle cell disease ADDENDA Nov. 7 & 8
Nov. 2, 2002	Management of thrombocytopenia associated with therapeutic plasma exchange (TPE), when the thrombocytopenia is believed to be heparin-induced ADDENDA Nov. 4 & 5
May 28, 2002	Maintaining patency of intravenous lines between repeated therapeutic hemapheresis procedures ADDENDA May 29 & June 8

Submit Comments to the e-Network Forum below:

Items marked with an asterisk (*) are required entries. Please note that there is a 60 minute time-out on this form. if one anticipates taking more than 30 minutes or so to compose the submission, we recommend composing your comments in a word processing application, and performing a copy and paste of your text into the comments field. "
* Name
Title
Affiliation
* email address
* Enter email address again to verify
* Do you wish to have attribution for your comments?	Yes No
* Your Comments
*Please indicate if this is a new question, or if you are commenting on an existing discussion:	New Question Existing, Name:
File Attachments (2MB limit)
To help us prevent SPAM, you must enter the the validation code EXACTLY AS IT IS DISPLAYED in the image directly to the right of the text entry field below in order to submit this form. Please note that the validation code is CASE SENSITIVE.